Arnav Kumar MD MSCR
Interventional Cardiology
Interventional & Structural Cardiologist
7400 Fannin St Suite 650Houston, TX 77054
Fax+1 855-227-3506
Overview of Dr. Kumar
Dr. Arnav Kumar is an interventional cardiologist specializing in valve disease and cardiogenic shock, based in Houston, TX. Dr. Kumar completed a fellowship in Cardiovascular Disease at Emory University School of Medicine and another in Interventional Cardiology & Structural Heart Disease at The Brigham and Women's Hospital. He has worked at several prominent Houston medical centers, including CHI St Luke's Health, Houston Methodist, and Memorial Hermann. Dr. Kumar has extensive experience with coronary artery disease, cardiogenic shock, aortic and mitral valve diseases. Publications include studies on TAVR, PCI wall shear stress, and various cardiac interventions. Additionally, Dr. Kumar has participated in clinical trials such as THRIVE and ARTEMIS.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Interventional Cardiology, 2021 - 2023
Emory University School of MedicineFellowship, Cardiovascular Disease, 2017 - 2021
Cleveland Clinic Lerner College of MedicineAdvanced Cardiac Imaging Research, 2015 - 2017
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2012 - 2015
Stanley Medical College SMCClass of 2010
Certifications & Licensure
GA State Medical License 2017 - 2027
TX State Medical License 2023 - 2027
RI State Medical License 2022 - 2024
MA State Medical License 2021 - 2023
OH State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension Start of enrollment: 2024 Oct 03
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Start of enrollment: 2024 Jun 25
- MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions Start of enrollment: 2024 Apr 16
Publications & Presentations
PubMed
- Development and Independent Validation of a Machine Learning-Based Non-Invasive Venous Waveform Analysis for Heart Failure (NIVA) Device to Estimate Pulmonary Capillar...Bret D Alvis, Jeffrey Schmeckpeper, Aniket S Rali, Jessica Huston, Stacy Tsai
Journal of Cardiac Failure. 2026-08-21 - A randomized prospective study investigating the relationship between post-PCI wall shear stress and 12-month neointimal healing: The SHEAR-STENT study.David S Molony, Olivia Hung, Michel Corban, Bill Gogas, Adrien Lefieux
Cardiovascular Revascularization Medicine. 2026-07-01 - Mild PVR After TAVR: Small Leak, Big Ocean of Consequences.Arnav Kumar, Yasser M Sammour, Hazim J Safi
JACC. Cardiovascular Interventions. 2026-01-12
Press Mentions
PCI During or After TAVR No Riskier Than PCI Before Valve ReplacementJune 19th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
